Long-term follow-up of therapeutic ERCP in 78 patients aged 90 years or older

Sci Rep. 2014 May 13:4:4918. doi: 10.1038/srep04918.

Abstract

This study aimed to determine the performance and long-term outcomes of therapeutic ERCP in very old patients. Patients aged or over 90 (Group A, n = 78) and consecutive sex-matched controls (Group B, n = 312) under 65 selected were compared. More patients in Group A had chronic concomitant diseases, but the success and complication rates were comparable. The follow-up of 61 patients (78.2%) in Group A were done, with a mean period of 27.5 (3-54) months. Seven patients survived; the main causes of death for the other patients were concomitant diseases (n = 43) and primary diseases (n = 11). In patients with choledocholithiasis, cases with complete extractions of stones in bile ducts survived longer than those without (30 vs. 24 months, P < 0.001). Therapeutic ERCP in patients aged 90 years or older is effective and safe. In patients with choledocholithiasis, complete clearance of stones is associated with longer survival time.

MeSH terms

  • Age Factors
  • Aged, 80 and over
  • Biliary Tract Diseases / diagnosis
  • Biliary Tract Diseases / mortality
  • Biliary Tract Diseases / therapy*
  • Cholangiopancreatography, Endoscopic Retrograde* / adverse effects
  • Cholangiopancreatography, Endoscopic Retrograde* / methods
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Pancreatic Diseases / diagnosis
  • Pancreatic Diseases / mortality
  • Pancreatic Diseases / therapy*
  • Treatment Outcome